ID Clinic Bangkok
ID Clinic Bangkok
Thailand, Bangkok
Dr Phatcharasak Kraisornphongsakul Md
34 years of experience • 20000+ treatments performed
Clinic is certified :
Stem cell therapy for HIV in Thailand typically costs from $12,000 / ฿408,000 to $18,000 / ฿612,000. Total expenses depend on the cell count, source of cells, and the clinic accreditation level. In the US, similar procedures cost around $60,000 / ฿2,040,000 on average. Thailand offers savings of around 75%. Packages often include pre-treatment viral load testing, stem cell infusions, and specialist consultations.
Bookimed Expert Insight: Choosing clinics with international laboratory certifications ensures high cell viability and safety. The Demarest Clinic in Phuket holds American Association of Blood Banks (AABB) accreditation for cell culturing. This level of certification is rare and matches top-tier Western standards. Meanwhile, specialists like Dr. Pichayanith Sroysuwan in Bangkok offer advanced NK cell booster therapies. These proprietary protocols provide excellent value for patients seeking systemic immune support alongside stem cell infusions.
| Thailand | Turkey | Austria | |
| Stem cell therapy for HIV | from $12,000 / ฿408,000 | from $18,000 / ฿612,000 | from $50,000 / ฿1,700,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell therapy for HIV upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell therapy for HIV and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell therapy for HIV journey.
Dr. Bee Thamonwan is an aesthetic and regenerative medicine specialist at Plenary Wellness in Phuket. She focus on natural rejuvenation using stem cells and collagen-boosting biostimulators. Dr. Thamonwan earned her medical degree from the Medical University of Lublin in Poland. She speaks Thai, English, and Chinese fluently.
Dr. Sitthisak Dhammawiatnukul is a specialist in regenerative medicine at Harmony Life Center in Bangkok. He holds ABAARM certification from the American Academy of Anti-Aging and Regenerative Medicine. He is a member of the International Society for Cellular Therapy (ISCT). Dr. Dhammawiatnukul focuses on non-surgical mesenchymal stem cell (MSC) therapy and hormone management.
Dr. Pichayanith Sroysuwan is a physician at Harmony Life Center in Bangkok. He holds dual certification from the American Board of Anti-Aging & Regenerative Medicine. He specializes in personalized wellness, stem cell therapy, and restorative medicine. Dr. Sroysuwan has completed over 63,000 procedures throughout his career.
Dr. Gorpong Koowattanataworn is a board-certified specialist in anti-aging and regenerative medicine at Harmony Life Center. He is certified by the American Board of Anti-Aging & Regenerative Medicine. Dr. Koowattanataworn focuses on longevity health, aesthetic dermatology, and cell-based therapies. He provides personalized treatments for knee restoration, hormone management, and immune health.
Thailand offers stem cell therapies for HIV primarily in Bangkok and Phuket at facilities overseen by the Thai Food and Drug Administration. Specialized centers like ID Clinic Bangkok and The Demarest Clinic operate alongside academic hubs like Thammasat University to provide regenerative protocols using mesenchymal stem cells.
Bookimed Expert Insight: While many seekers focus on Bangkok, clinics in Phuket like The Demarest Clinic differentiate themselves by integrating in-house satellite medical laboratories and global researcher networks. This infrastructure allows for real-time protocol updates that smaller medical spas cannot match despite similar marketing claims.
Patient Consensus: Patients emphasize the need to verify Thai FDA approval directly and warn against clinics making unverified success claims. Many advise prioritizing standard antiretroviral therapy while researching experimental options to avoid unsubstantiated medical outcomes.